Is CRISM' Therapeutics Corp halal to invest in?

As of July 2026, CRISM' Therapeutics Corp A7L.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is CRISM' Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CRISM' Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of CRISM' Therapeutics Corp?

Muslim investors may consider investing in CRISM' Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is CRISM' Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of CRISM' Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for CRISM' Therapeutics Corp updated?

The Shariah compliance status of CRISM' Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like CRISM' Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of CRISM' Therapeutics Corp?

You can check the latest Shariah compliance status of CRISM' Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CRISM' Therapeutics Corp A7L.SG

Last Updated: Jun 01, 12:00 AM·XSTU

A7L.SG Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, CRISM' Therapeutics Corp is classified as not halal.

NOT HALAL

Report Source: 2025 2nd Quarter Report

CRISM' Therapeutics Corp. Stock Analysis A7L.SG

Germany Health Care Nano Cap Report: Q2, 2025

CRISM Therapeutics Corp. is a biotechnology company, which engages in the development of cancer treatment drugs for solid tumors. The firm has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. The company seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The firm also offers formulation and consultancy services. The company provides assistance and services to improve the bioavailability of poorly soluble drugs. The company offers remixers and extruders of various sizes.

Key Statistics of CRISM' Therapeutics Corp (A7L.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.01€0.01

Today's Open

€0.01

Volume

P/E Ratio (TTM)

Financial Metrics & Statements of CRISM' Therapeutics Corp (A7L.SG)

Super Investors Invested in CRISM' Therapeutics Corp (A7L.SG)

FAQ's for CRISM' Therapeutics Corp (A7L.SG)

As of July 2026, CRISM' Therapeutics Corp A7L.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CRISM' Therapeutics Corp using these criteria to determine its compliance status.
Muslim investors may consider investing in CRISM' Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of CRISM' Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of CRISM' Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of CRISM' Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.